RARITAN, N.J., Oct. 18, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a suite of extended antigen phenotyping, has been ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that ORTHO Sera, a suite of extended antigen phenotyping, has been cleared by the US Food and Drug Administration for use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback